Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection

Shamir R. Jacobino; Maaike Nederend; Marije Hennus; Michiel L. Houben; Joan O. Ngwuta; Marco Viveen; Frank E.J. Coenjaerts; C. Erik Hack; R. J.Joost van Neerven; Barney S. Graham; Louis Bont; Jeanette H.W. Leusen

doi:10.1016/j.jaci.2016.06.001

Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection

Shamir R. Jacobino, Maaike Nederend, Marije Hennus, Michiel L. Houben, Joan O. Ngwuta, Marco Viveen, Frank E.J. Coenjaerts, C. Erik Hack, R. J.Joost van Neerven, Barney S. Graham, Louis Bont, Jeanette H.W. Leusen

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

9 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	1477-1480.e5
Tijdschrift	Journal of Allergy and Clinical Immunology
Volume	138
Nummer van het tijdschrift	5
DOI's	https://doi.org/10.1016/j.jaci.2016.06.001
Status	Gepubliceerd - 1 nov. 2016
Extern gepubliceerd	Ja

Toegang tot document

10.1016/j.jaci.2016.06.001

Citeer dit

Jacobino, S. R., Nederend, M., Hennus, M., Houben, M. L., Ngwuta, J. O., Viveen, M., Coenjaerts, F. E. J., Hack, C. E., van Neerven, R. J. J., Graham, B. S., Bont, L., & Leusen, J. H. W. (2016). Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection. Journal of Allergy and Clinical Immunology, 138(5), 1477-1480.e5. https://doi.org/10.1016/j.jaci.2016.06.001

@article{037e311795e14cd4b3ee920066cd086a,

title = "Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection",

author = "Jacobino, {Shamir R.} and Maaike Nederend and Marije Hennus and Houben, {Michiel L.} and Ngwuta, {Joan O.} and Marco Viveen and Coenjaerts, {Frank E.J.} and Hack, {C. Erik} and {van Neerven}, {R. J.Joost} and Graham, {Barney S.} and Louis Bont and Leusen, {Jeanette H.W.}",

note = "Funding Information: Disclosure of potential conflict of interest: S. R. Jacobino has received research support from the University of Utrecht (European Research Council stimulation grant). M. Nederend has received research support from the Dutch Technology Foundation (Stichting voor de Technische Wetenshappen project 13017). M. L. Houben has received research support from European Society for Pediatric Infectious Diseases and Dutch Asthma Foundation. R. J. J. van Neerven is employed by FrieslandCampina (Amersfoort, The Netherlands), which was not in any way involved in this study, and is inventor on a few patent applications through FrieslandCampina. L. Bont has received consultancy fees from AbbVie, MedImmune, Ablynx, Janssen, and Novavax; has received research support from AbbVie, MedImmune, Janssen, and MeMed; and has received lecture fees from AbbVie. The rest of the authors declare that they have no relevant conflicts of interest. ",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/j.jaci.2016.06.001",

language = "English",

volume = "138",

pages = "1477--1480.e5",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "5",

}

Jacobino, SR, Nederend, M, Hennus, M, Houben, ML, Ngwuta, JO, Viveen, M, Coenjaerts, FEJ, Hack, CE, van Neerven, RJJ, Graham, BS, Bont, L & Leusen, JHW 2016, 'Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection', Journal of Allergy and Clinical Immunology, vol. 138, nr. 5, blz. 1477-1480.e5. https://doi.org/10.1016/j.jaci.2016.06.001

TY - JOUR

T1 - Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection

AU - Jacobino, Shamir R.

AU - Nederend, Maaike

AU - Hennus, Marije

AU - Houben, Michiel L.

AU - Ngwuta, Joan O.

AU - Viveen, Marco

AU - Coenjaerts, Frank E.J.

AU - Hack, C. Erik

AU - van Neerven, R. J.Joost

AU - Graham, Barney S.

AU - Bont, Louis

AU - Leusen, Jeanette H.W.

N1 - Funding Information: Disclosure of potential conflict of interest: S. R. Jacobino has received research support from the University of Utrecht (European Research Council stimulation grant). M. Nederend has received research support from the Dutch Technology Foundation (Stichting voor de Technische Wetenshappen project 13017). M. L. Houben has received research support from European Society for Pediatric Infectious Diseases and Dutch Asthma Foundation. R. J. J. van Neerven is employed by FrieslandCampina (Amersfoort, The Netherlands), which was not in any way involved in this study, and is inventor on a few patent applications through FrieslandCampina. L. Bont has received consultancy fees from AbbVie, MedImmune, Ablynx, Janssen, and Novavax; has received research support from AbbVie, MedImmune, Janssen, and MeMed; and has received lecture fees from AbbVie. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2016/11/1

Y1 - 2016/11/1

UR - http://www.scopus.com/inward/record.url?scp=84979582479&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2016.06.001

DO - 10.1016/j.jaci.2016.06.001

M3 - Article

C2 - 27448445

AN - SCOPUS:84979582479

SN - 0091-6749

VL - 138

SP - 1477-1480.e5

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -